| UniProt ID | PGAM5_HUMAN | |
|---|---|---|
| UniProt AC | Q96HS1 | |
| Protein Name | Serine/threonine-protein phosphatase PGAM5, mitochondrial | |
| Gene Name | PGAM5 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 289 | |
| Subcellular Localization |
Mitochondrion outer membrane Single-pass membrane protein . Isoform 2 overexpression results in the formation of disconnected punctuate mitochondria distributed throughout the cytoplasm. Isoform 1 overexpression results in the clustering of mitocho |
|
| Protein Description | Displays phosphatase activity for serine/threonine residues, and, dephosphorylates and activates MAP3K5 kinase. Has apparently no phosphoglycerate mutase activity. May be regulator of mitochondrial dynamics. Substrate for a KEAP1-dependent ubiquitin ligase complex. Contributes to the repression of NFE2L2-dependent gene expression. Acts as a central mediator for programmed necrosis induced by TNF, by reactive oxygen species and by calcium ionophore.. | |
| Protein Sequence | MAFRQALQLAACGLAGGSAAVLFSAVAVGKPRAGGDAEPRPAEPPAWAGGARPGPGVWDPNWDRREPLSLINVRKRNVESGEEELASKLDHYKAKATRHIFLIRHSQYHVDGSLEKDRTLTPLGREQAELTGLRLASLGLKFNKIVHSSMTRAIETTDIISRHLPGVCKVSTDLLREGAPIEPDPPVSHWKPEAVQYYEDGARIEAAFRNYIHRADARQEEDSYEIFICHANVIRYIVCRALQFPPEGWLRLSLNNGSITHLVIRPNGRVALRTLGDTGFMPPDKITRS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 75 | Acetylation | LSLINVRKRNVESGE CCCEEEHHHCCCCCH | 44.00 | 20167786 | |
| 75 | Ubiquitination | LSLINVRKRNVESGE CCCEEEHHHCCCCCH | 44.00 | - | |
| 80 | Phosphorylation | VRKRNVESGEEELAS EHHHCCCCCHHHHHH | 47.42 | 23401153 | |
| 87 | Phosphorylation | SGEEELASKLDHYKA CCHHHHHHHHHHHHH | 46.50 | 30266825 | |
| 88 (in isoform 2) | Ubiquitination | - | 52.94 | 21890473 | |
| 88 | Ubiquitination | GEEELASKLDHYKAK CHHHHHHHHHHHHHH | 52.94 | 21890473 | |
| 88 | Ubiquitination | GEEELASKLDHYKAK CHHHHHHHHHHHHHH | 52.94 | 23000965 | |
| 88 | 2-Hydroxyisobutyrylation | GEEELASKLDHYKAK CHHHHHHHHHHHHHH | 52.94 | - | |
| 88 | Acetylation | GEEELASKLDHYKAK CHHHHHHHHHHHHHH | 52.94 | 23954790 | |
| 88 (in isoform 1) | Ubiquitination | - | 52.94 | 21890473 | |
| 88 | Malonylation | GEEELASKLDHYKAK CHHHHHHHHHHHHHH | 52.94 | 26320211 | |
| 88 | Ubiquitination | GEEELASKLDHYKAK CHHHHHHHHHHHHHH | 52.94 | 21890473 | |
| 92 | Phosphorylation | LASKLDHYKAKATRH HHHHHHHHHHHHHEE | 16.59 | 30266825 | |
| 93 | Ubiquitination | ASKLDHYKAKATRHI HHHHHHHHHHHHEEE | 39.74 | 23000965 | |
| 93 | Acetylation | ASKLDHYKAKATRHI HHHHHHHHHHHHEEE | 39.74 | 23749302 | |
| 93 | 2-Hydroxyisobutyrylation | ASKLDHYKAKATRHI HHHHHHHHHHHHEEE | 39.74 | - | |
| 106 | Phosphorylation | HIFLIRHSQYHVDGS EEEEEECCEEECCCC | 23.68 | 20860994 | |
| 108 | Phosphorylation | FLIRHSQYHVDGSLE EEEECCEEECCCCCC | 13.56 | 20860994 | |
| 113 | Phosphorylation | SQYHVDGSLEKDRTL CEEECCCCCCCCCCC | 28.97 | 29214152 | |
| 116 | Ubiquitination | HVDGSLEKDRTLTPL ECCCCCCCCCCCCCC | 58.78 | 22505724 | |
| 116 | Acetylation | HVDGSLEKDRTLTPL ECCCCCCCCCCCCCC | 58.78 | 19608861 | |
| 116 | 2-Hydroxyisobutyrylation | HVDGSLEKDRTLTPL ECCCCCCCCCCCCCC | 58.78 | - | |
| 131 | Phosphorylation | GREQAELTGLRLASL CHHHHHHHCHHHHHH | 26.19 | 20068231 | |
| 141 | Ubiquitination | RLASLGLKFNKIVHS HHHHHCCCHHHHHHH | 45.13 | 23000965 | |
| 141 (in isoform 1) | Ubiquitination | - | 45.13 | 21890473 | |
| 141 | Ubiquitination | RLASLGLKFNKIVHS HHHHHCCCHHHHHHH | 45.13 | 21890473 | |
| 141 | Ubiquitination | RLASLGLKFNKIVHS HHHHHCCCHHHHHHH | 45.13 | 21890473 | |
| 141 | Neddylation | RLASLGLKFNKIVHS HHHHHCCCHHHHHHH | 45.13 | 32015554 | |
| 141 | 2-Hydroxyisobutyrylation | RLASLGLKFNKIVHS HHHHHCCCHHHHHHH | 45.13 | - | |
| 141 | Acetylation | RLASLGLKFNKIVHS HHHHHCCCHHHHHHH | 45.13 | 25825284 | |
| 141 (in isoform 2) | Ubiquitination | - | 45.13 | 21890473 | |
| 144 | Malonylation | SLGLKFNKIVHSSMT HHCCCHHHHHHHHHC | 49.60 | 32601280 | |
| 144 | Ubiquitination | SLGLKFNKIVHSSMT HHCCCHHHHHHHHHC | 49.60 | 23000965 | |
| 144 | Acetylation | SLGLKFNKIVHSSMT HHCCCHHHHHHHHHC | 49.60 | 19608861 | |
| 148 | Phosphorylation | KFNKIVHSSMTRAIE CHHHHHHHHHCHHHH | 15.77 | 30001349 | |
| 149 | Phosphorylation | FNKIVHSSMTRAIET HHHHHHHHHCHHHHH | 14.86 | 30001349 | |
| 151 | Phosphorylation | KIVHSSMTRAIETTD HHHHHHHCHHHHHHH | 20.92 | 30001349 | |
| 156 | Phosphorylation | SMTRAIETTDIISRH HHCHHHHHHHHHHHH | 24.53 | 27251275 | |
| 157 | Phosphorylation | MTRAIETTDIISRHL HCHHHHHHHHHHHHC | 16.65 | 27251275 | |
| 161 | Phosphorylation | IETTDIISRHLPGVC HHHHHHHHHHCCCCE | 17.62 | 27251275 | |
| 168 | S-palmitoylation | SRHLPGVCKVSTDLL HHHCCCCEEECHHHH | 4.46 | 21044946 | |
| 169 (in isoform 1) | Ubiquitination | - | 36.49 | 21890473 | |
| 169 (in isoform 2) | Ubiquitination | - | 36.49 | 21890473 | |
| 169 | Ubiquitination | RHLPGVCKVSTDLLR HHCCCCEEECHHHHH | 36.49 | 22817900 | |
| 169 | Acetylation | RHLPGVCKVSTDLLR HHCCCCEEECHHHHH | 36.49 | 25953088 | |
| 171 | Phosphorylation | LPGVCKVSTDLLREG CCCCEEECHHHHHCC | 11.16 | 23312004 | |
| 172 | Phosphorylation | PGVCKVSTDLLREGA CCCEEECHHHHHCCC | 33.38 | 23312004 | |
| 188 | Phosphorylation | IEPDPPVSHWKPEAV CCCCCCCCCCCHHHH | 29.42 | 30108239 | |
| 191 | Ubiquitination | DPPVSHWKPEAVQYY CCCCCCCCHHHHHHH | 27.79 | 19608861 | |
| 191 | Acetylation | DPPVSHWKPEAVQYY CCCCCCCCHHHHHHH | 27.79 | 19608861 | |
| 197 | Phosphorylation | WKPEAVQYYEDGARI CCHHHHHHHHCCHHH | 11.39 | 30108239 | |
| 198 | Phosphorylation | KPEAVQYYEDGARIE CHHHHHHHHCCHHHH | 7.17 | 30108239 | |
| 253 | Phosphorylation | PEGWLRLSLNNGSIT CCCEEEEEECCCCEE | 23.71 | 29523821 | |
| 258 | Phosphorylation | RLSLNNGSITHLVIR EEEECCCCEEEEEEC | 26.83 | 29523821 | |
| 284 | Ubiquitination | DTGFMPPDKITRS-- CCCCCCCHHCCCC-- | 49.47 | 24816145 | |
| 285 | Ubiquitination | TGFMPPDKITRS--- CCCCCCHHCCCC--- | 52.32 | 24816145 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
| - | K | Ubiquitination | E3 ubiquitin ligase | XIAP | P98170 | PMID:23201124 |
| - | K | Ubiquitination | E3 ubiquitin ligase | BIRC2 | Q13490 | PMID:23201124 |
| - | K | Ubiquitination | E3 ubiquitin ligase | KEAP1 | Q14145 | PMID:17046835 |
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of PGAM5_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of PGAM5_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| SETB1_HUMAN | SETDB1 | physical | 16169070 | |
| ZBT16_HUMAN | ZBTB16 | physical | 16169070 | |
| KEAP1_HUMAN | KEAP1 | physical | 17046835 | |
| B2CL1_HUMAN | BCL2L1 | physical | 17046835 | |
| CUL3_HUMAN | CUL3 | physical | 17046835 | |
| RBX1_HUMAN | RBX1 | physical | 17046835 | |
| PINK1_HUMAN | PINK1 | physical | 21151955 | |
| KEAP1_HUMAN | KEAP1 | physical | 18387606 | |
| BIRC2_HUMAN | BIRC2 | physical | 23201124 | |
| XIAP_HUMAN | XIAP | physical | 23201124 | |
| PGAM5_HUMAN | PGAM5 | physical | 27218139 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-116; LYS-144 AND LYS-191,AND MASS SPECTROMETRY. | |